Janessa Laskin

Janessa Laskin

UNVERIFIED PROFILE

Are you Janessa Laskin?   Register this Author

Register author
Janessa Laskin

Janessa Laskin

Publications by authors named "Janessa Laskin"

Are you Janessa Laskin?   Register this Author

93Publications

1882Reads

20Profile Views

Emotional distress and psychosocial needs in patients with breast cancer in British Columbia: younger versus older adults.

Breast Cancer Res Treat 2020 Jan 19;179(2):471-477. Epub 2019 Oct 19.

University of British Columbia, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-019-05468-6DOI Listing
January 2020

The pivotal role of sampling recurrent tumors in the precision care of patients with tumors of the central nervous system.

Cold Spring Harb Mol Case Stud 2019 08 1;5(4). Epub 2019 Aug 1.

Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia V6T 2B5, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/mcs.a004143DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6672021PMC
August 2019

ALK-Positive Lung Adenocarcinoma Arising in an Adolescent Treated for Relapsed Neuroblastoma.

J Thorac Oncol 2019 06;14(6):e132-e135

Division of Anatomical Pathology, British Columbia Children's Hospital; and Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S15560864193011
Publisher Site
http://dx.doi.org/10.1016/j.jtho.2019.02.010DOI Listing
June 2019

Assessing the psychosocial needs of newly diagnosed patients with nonsmall cell lung cancer: Identifying factors associated with distress.

Psychooncology 2019 04 27;28(4):815-821. Epub 2019 Feb 27.

Department of Medical Oncology, BC Cancer, Vancouver, British Columbia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pon.5025DOI Listing
April 2019

Detection and genomic characterization of a mammary-like adenocarcinoma.

Cold Spring Harb Mol Case Stud 2017 Nov 21;3(6). Epub 2017 Nov 21.

Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia V5Z 1L3, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1101/mcs.a002170DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701302PMC
November 2017

Adherence to surveillance guidelines in resected NSCLC: Physician compliance and impact on outcomes.

Lung Cancer 2017 10 19;112:176-180. Epub 2017 Aug 19.

Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2017.08.012DOI Listing
October 2017

A retrospective review of the multidisciplinary management of medullary thyroid cancer: eligibility for systemic therapy.

Thyroid Res 2017 19;10. Epub 2017 Sep 19.

Medical Oncology, British Columbia Cancer Agency, 600 W 10th Avenue, Vancouver, BC V5Z 4E6 Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13044-017-0041-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5606127PMC
September 2017

Knowledge, attitudes, and values among physicians working with clinical genomics: a survey of medical oncologists.

Hum Resour Health 2017 06 27;15(1):42. Epub 2017 Jun 27.

British Columbia Cancer Agency, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12960-017-0218-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5488429PMC
June 2017

The cost and cost trajectory of whole-genome analysis guiding treatment of patients with advanced cancers.

Mol Genet Genomic Med 2017 May 12;5(3):251-260. Epub 2017 Mar 12.

Canadian Centre for Applied Research in Cancer Control (ARCC)Cancer Control ResearchBC Cancer AgencyVancouverBritish ColumbiaCanada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/mgg3.281DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5441418PMC
May 2017

Asian Versus Non-Asian Outcomes in Nasopharyngeal Carcinoma: A North American Population-based Analysis.

Am J Clin Oncol 2016 12;39(6):575-580

*Departments of Radiation Oncology ‡Medical Oncology ¶Population Oncology-Surveillance and Outcomes, British Columbia Cancer Agency §Department of Medicine †Department of Surgery, University of British Columbia, Vancouver, BC, Canada ∥Department of Statistics.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000091DOI Listing
December 2016

ETV6-NTRK3 Is Expressed in a Subset of ALK-Negative Inflammatory Myofibroblastic Tumors.

Am J Surg Pathol 2016 08;40(8):1051-61

*Department of Pathology, Vancouver General Hospital §Genome Sciences Center ∥British Columbia Cancer Agency ¶British Columbia Children's Hospital #Department of Pathology, University of British Columbia, Vancouver, BC **Department of Pathology, Royal Alexandra Hospital, Edmonton, AB, Canada †Department of Pathology, King Abdulaziz Medical City, Riyadh, Saudi Arabia ‡Department of Pathology, Kuwait University, Kuwait.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000677DOI Listing
August 2016

ATM, THMS, and RRM1 protein expression in nasopharyngeal carcinomas treated with curative intent.

Head Neck 2016 04 29;38 Suppl 1:E384-91. Epub 2015 Jun 29.

Department of Medical Oncology, Tom Baker Cancer Centre, University of Calgary, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.24004DOI Listing
April 2016

Pan Canadian Rash Trial: A Randomized Phase III Trial Evaluating the Impact of a Prophylactic Skin Treatment Regimen on Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor-Induced Skin Toxicities in Patients With Metastatic Lung Cancer.

J Clin Oncol 2016 Mar 16;34(8):810-5. Epub 2015 Nov 16.

Barbara Melosky, Vincent Ho, Cheryl Ho, Nevin Murray, Sophie Sun, and Janessa J. Laskin, British Columbia Cancer Agency (BCCA) Vancouver Centre, Vancouver; Helen Anderson, BCCA Vancouver Island Centre, Victoria; Wendy Lam, Burnaby Regional Hospital, Burnaby; Christopher W. Lee, BCCA Fraser Valley Cancer Centre, Surrey; Robert Winston, BCCA Abbotsford Centre, Abbotsford, British Columbia; Ronald L. Burkes, Mount Sinai Hospital; Natasha B. Leighl, Princess Margaret Cancer Centre, Toronto, Ontario; Quincy Chu, Cross Cancer Institute, Edmonton; and Desiree Hao, Tom Baker Care Centre, Calgary, Alberta, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.62.3918DOI Listing
March 2016

Implementation of a Lung Cancer Nurse Navigator Enhances Patient Care and Delivery of Systemic Therapy at the British Columbia Cancer Agency, Vancouver.

J Oncol Pract 2016 Mar 16;12(3):e344-9. Epub 2016 Feb 16.

British Columbia Cancer Agency, Vancouver, British Columbia, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JOP.2015.008813DOI Listing
March 2016

The Influence of the Evolution of First-Line Chemotherapy on Steadily Improving Survival in Advanced Non-Small-Cell Lung Cancer Clinical Trials.

J Thorac Oncol 2015 Nov;10(11):1523-31

Department of Medical Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000667DOI Listing
November 2015

Integrative genomic analysis of ghost cell odontogenic carcinoma.

Oral Oncol 2015 Sep 11;51(9):e71-5. Epub 2015 Jul 11.

Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada; Department of Molecular Biology and Biochemistry, Simon Fraser University, Burnaby, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2015.06.013DOI Listing
September 2015

Maintenance chemotherapy in advanced NSCLC: a population-based assessment of eligibility.

Lung Cancer 2015 Mar 5;87(3):296-302. Epub 2015 Jan 5.

Department of Medical Oncology, BC Cancer Agency, Vancouver, BC, Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2014.12.014DOI Listing
March 2015

Toxicity and outcomes in combined modality treatment of head and neck squamous cell carcinoma: cisplatin versus cetuximab.

J Cancer Res Ther 2013 Oct-Dec;9(4):607-12

Systemic Therapy Programs, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0973-1482.126455DOI Listing
December 2014

Referral patterns in advanced non-small cell lung cancer: impact on delivery of treatment and survival in a contemporary population based cohort.

Lung Cancer 2014 Dec 2;86(3):344-9. Epub 2014 Oct 2.

Department of Medical Oncology, BC Cancer Agency, 600 West 10th Avenue, Vancouver, BC, V5Z 4E6 Canada. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2014.09.016DOI Listing
December 2014

Less toxic chemotherapy improves uptake of all lines of chemotherapy in advanced non-small-cell lung cancer: a 10-year retrospective population-based review.

J Thorac Oncol 2014 Aug;9(8):1180-6

*Medical Oncology, BC Cancer Agency, Vancouver, BC; and †Department of Statistics, University of British Columbia, Vancouver, BC.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000225DOI Listing
August 2014

Diagnostic value of next-generation sequencing in an unusual sphenoid tumor.

Oncologist 2014 Jun 7;19(6):623-30. Epub 2014 May 7.

Centre for Translational and Applied Genomics, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Canada's Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; British Columbia Cancer Research Centre, Vancouver, British Columbia, Canada; Division of Oncology/Hematology/BMT, Department of Pediatrics, University of British Columbia, Vancouver, British Columbia, Canada; Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada; Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2013-0390DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041668PMC
June 2014

Dose delivery analysis of weekly versus 3-weekly cisplatin concurrent with radiation therapy for locally advanced nasopharyngeal carcinoma (NPC).

Am J Clin Oncol 2014 Feb;37(1):63-9

*Department of Medicine, University of British Columbia Departments of †Medical Oncology §Radiation Oncology, British Columbia Cancer Agency, Vancouver, BC ‡Department of Medical Oncology, Tom Baker Cancer Centre, Calgary, AB, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0b013e31826b9b1aDOI Listing
February 2014

Assessment of ERCC1 and XPF protein expression using quantitative immunohistochemistry in nasopharyngeal carcinoma patients undergoing curative intent treatment.

Int J Radiat Oncol Biol Phys 2013 Apr 22;85(5):1340-5. Epub 2012 Nov 22.

Department of Internal Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2012.09.032DOI Listing
April 2013

Thymoma: a population-based study of the management and outcomes for the province of British Columbia.

J Thorac Oncol 2013 Jan;8(1):109-17

Department of British Columbia Cancer Agency, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318276241cDOI Listing
January 2013

Beta-catenin expression is prognostic of improved non-small cell lung cancer survival.

Am J Surg 2012 May 7;203(5):654-659. Epub 2012 Mar 7.

Department of Surgery, St. Paul's Hospital, University of British Columbia, C303-1081 Burrard Street, Vancouver, BC, Canada V6Z 1Y6. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjsurg.2012.01.002DOI Listing
May 2012

Locally Advanced Cutaneous Squamous Cell Carcinoma: Two Case Reports of Dramatic Responses to Sequential Cisplatin, Docetaxel and Radiotherapy.

World J Oncol 2011 Aug 24;2(4):199-203. Epub 2011 Aug 24.

Division of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4021/wjon328wDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5649659PMC
August 2011

A phase II study of carboplatin and irinotecan in extensive stage small-cell lung cancer.

Clin Lung Cancer 2011 May 27;12(3):161-5. Epub 2011 Apr 27.

Vanderbilt Ingram Cancer Center, Nashville, TN, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cllc.2011.03.013DOI Listing
May 2011

Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples.

Am J Surg Pathol 2010 Dec;34(12):1805-11

Department of Pathology, BC Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0b013e3181f7dae3DOI Listing
December 2010

Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study.

Lancet Oncol 2010 Aug 23;11(8):733-40. Epub 2010 Jul 23.

Department of Oncology, Hospital Santa Maria della Misericordia, Sant Andrea delle Fratte, Perugia, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(10)70151-0DOI Listing
August 2010

EGFR-directed therapies to treat non-small-cell lung cancer.

Expert Opin Investig Drugs 2009 Aug;18(8):1133-45

British Columbia Cancer Agency, Medical Oncologist, 600 W 10th Avenue, Vancouver, BC V5Z 4E6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543780903066772DOI Listing
August 2009

BCL-2 expression is prognostic for improved survival in non-small cell lung cancer.

J Thorac Oncol 2009 Apr;4(4):486-91

Division of Medical Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0b013e318199e03aDOI Listing
April 2009

Nonsmall cell lung carcinoma with neuroendocrine differentiation--an entity of no clinical or prognostic significance.

Am J Surg Pathol 2007 Jan;31(1):26-32

Pathology and Laboratory Medicine, Vancouver General Hospital, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/01.pas.0000213319.04919.97DOI Listing
January 2007

A new era for bronchioloalveolar carcinoma: current state of the art and recent advances in biologically targeted therapy.

Expert Rev Anticancer Ther 2006 Oct;6(10):1411-9

University of British Columbia, BC Cancer Agency, Vancouver, BC, V5Z 4E6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737140.6.10.1411DOI Listing
October 2006

Primary paranasal sinus lymphoma: natural history and improved outcome with central nervous system chemoprophylaxis.

Leuk Lymphoma 2005 Dec;46(12):1721-7

Division of Medical Oncology, University of British Columbia and the British Columbia Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17402520500182345DOI Listing
December 2005

First-line treatment for advanced non-small-cell lung cancer.

Oncology (Williston Park) 2005 Nov;19(13):1671-6; discussion 1678-80

Division of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
November 2005

Epidermal growth factor receptor inhibitors in lung cancer therapy.

Semin Respir Crit Care Med 2004 ;25 Suppl 1:17-27

Division of Medical Oncology, BC Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-2004-829641DOI Listing
October 2005

State of the art in therapy for non-small cell lung cancer.

Cancer Invest 2005 ;23(5):427-42

Division of Medical Oncology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1081/cnv-67172DOI Listing
October 2005

The formulation of lipid-based nanotechnologies for the delivery of fixed dose anticancer drug combinations.

Curr Drug Deliv 2005 Oct;2(4):341-51

Advanced Therapeutics, British Columbia Cancer Agency, 675 West 10th Avenue, Vancouver, BC V5Z 1L3, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/156720105774370294DOI Listing
October 2005

Adjuvant chemotherapy for non-small cell lung cancer: the new standard of care.

Authors:
Janessa J Laskin

Future Oncol 2005 Oct;1(5):619-23

University of British Columbia, Division of Medical Oncology, Assistant Professor of Medicine, British Columbia Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/14796694.1.5.619DOI Listing
October 2005

Redefining bronchioloalveolar carcinoma.

Semin Oncol 2005 Jun;32(3):329-35

Department of Medicine, Division of Medical Oncology, University of British Columbia, BC Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2005.02.013DOI Listing
June 2005

Bronchoalveolar carcinoma: current treatment and future trends.

Authors:
Janessa J Laskin

Clin Lung Cancer 2004 Dec;6 Suppl 2:S75-9

University of British Columbia, Division of Medical Oncology, BC Cancer Agency, Vancouver, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3816/clc.2004.s.018DOI Listing
December 2004

Epidermal growth factor receptor: a promising target in solid tumours.

Cancer Treat Rev 2004 Feb;30(1):1-17

Division of Medical Oncology, British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, BC V5Z 4E6, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ctrv.2003.10.002DOI Listing
February 2004

Population-based outcomes for small cell lung cancer: impact of standard management policies in British Columbia.

Lung Cancer 2004 Jan;43(1):7-16

Division of Medical Oncology, British Columbia Cancer Agency, 600 West 10th Avenue, Vancouver, BC, Canada V5Z 4E6.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2003.07.004DOI Listing
January 2004

The role of prophylactic cranial radiation in the treatment of non-small-cell lung cancer.

Clin Adv Hematol Oncol 2003 Dec;1(12):731-34

British Columbia Cancer Agency, Vancouver, BC, Canada.

View Article

Download full-text PDF

Source
December 2003

The importance of the eicosanoid pathway in lung cancer.

Lung Cancer 2003 Aug;41 Suppl 1:S73-9

Department of Medical Oncology and Hematology, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, 777 PRB, Nashville, TN 37215-6307, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0169-5002(03)00145-4DOI Listing
August 2003

An advance in small-cell lung cancer treatment--more or less.

J Natl Cancer Inst 2003 Aug;95(15):1099-101

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djg013DOI Listing
August 2003